Loading...

Impact of regulatory structure on quality of medicines in India

345 views

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 4, 2016

Speaker: Dinesh Thakur, Executive Chairman of Medassure Global Compliance Corporation.
Quality of medicines dispensed in the Indian market has been an area of concern for quite some time now. Prosecution of Ranbaxy Laboratories, once India's largest pharmaceutical company in the US bought issues of data integrity and product quality to light. Since that time, foreign regulators like the US FDA and the EMA have increased their focus on Indian manufacturers to make sure that the medicines made in India and sold in those markets are of high quality. Unfortunately, precious little has changed in India. One of the key challenges to creating public awareness about this issue is the lack of think-tanks and research organizations which focus on this issue. This talk outlines the efforts undertaken to approach the Supreme Court challenging the constitutionality of the legal framework that forms the basis of drug regulation with an intent to develop a better understanding among policy analysts.
http://macrofinance.nipfp.org.in/

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...